References
- Hardiman O, Al Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.
- Hanisch UK, Kettenman H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387–94.
- Confavreux C, Moreau T, Jouvet A, Tommasi M, Aimard G. Association sclérose latérale amyotrophique et sclérose en plaques. Rev Neurol. 1993;149:351–3.
- Li G, Esiri MM, Ansorge O, De Luca G. Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet? J Neuroinflammation. 2012;9:20.
- Hader WJ, Rpzdilsky B, Nair CP. The concurrence of multiple sclerosis and amyotrophic lateral sclerosis. Can J Neurol Sci. 1996;13:66–9.
- Borisow N, Thomas Meyer T, Friedemann P. Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship? BMJ Case Rep. 2013;23:2013.
- Machner B, Gottschalk S, Kimming H, Helmchen C. Simultaneous presentation of amyotrophic lateral sclerosis and multiple sclerosis. Nervenartz. 2007;78:1440–3.
- Dynes G, Schwimer C, Staugaitis M, Doyle J, Hays AP, Mitsumoto H. Amyotrophic lateral sclerosis with multiple sclerosis: a clinical and pathological report. ALS Other Motor Neuron Disord. 2000;1:349–53.
- Trojsi F, Sagnelli A, Cirillo G, et al. Amyotrophic lateral sclerosis and multiple sclerosis overlap: a case report. Case Rep Med. 2012;2012:324685.
- Ismail A, Cooper-Knock J, Highley R, et al. Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. J Neurol Neurosurg Psychiatry. 2013;84:79–87.
- Dattola V, Famà F, Russo M, et al. Multiple sclerosis and amyotrophic lateral sclerosis: a human leukocyte antigen challenge. Neurol Sci. 2017;38:1501–3.
- Allen J, Stein R, Baker R, et al. Muscle atrophy associated with multiple sclerosis: a benign condition or the onset of amyotrophic lateral sclerosis? J Clin Neurosci. 2008;15:706–8.
- González H, Pacheco R. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation. 2014;11:201.
- van den Berg R, Hoogenraad CC, Hintzen RQ. Axonal transport deficits in multiple sclerosis: spiraling into the abyss. Acta Neuropathol. 2017;134:1–14.
- Steele JC, McGeer PL. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2008;70:1984–90.
- Hemminki K, Li X, Sundquist J, Hillert J, Sundquist K. Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics. 2009;10:5–11.
- Etemadifar M, Abtahi S, Abkari M, Maghzi A. Multiple sclerosis and amyotrophic lateral sclerosis: is there a link? Mult Scler. 2012;18:902–4.
- Leray E, Yaouanq J, Le Page E, et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain. 2010;133:1900–13.
- Mitsumoto H, Brooks BR, Silani V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol. 2014;13:1127–38.
- Waubant E, Maghzi AH, Revirajan N, et al. A randomized controlled phase II trial of Riluzole in early multiple sclerosis. Ann Clin Transl Neurol. 2014;1:340–7.